Digital Therapeutics Market 2022 Business Analysis, Share, Comprehensive Research Study, Future Plans, Competitive Landscape and Forecast to 2030 | Livongo Health, Inc., Omada Health, Inc., Proteus Digital Health, Inc., Akili Interactive Labs, Inc., 2Morr

Astute Analytica publishes a research report on the global digital therapeutics market. The analysis report contains in-depth data about demand, growth, opportunities, challenges, and restraints. In addition, it provides a thorough examination of the structure and possibility of global and regional industries.

The Global Digital Therapeutics Market is estimated to witness a major jump in revenue from US$ 3,744.3 Million in 2021 to US$ 24,143.3 Million by 2030. The market is registering a CAGR of 23.1% over the projection period 2022-2030.

Request To Download Sample of This Strategic Report- https://www.astuteanalytica.com/request-sample/digital-therapeutics-market

The global market study includes information from key firms on R&D, new product launches, and product responses from global markets. The analysis includes a graphical presentation and a diagrammatic examination of the global market by region.

People and economies globally rely substantially on the healthcare business. It is one of the fastest-growing industries. There is a correlation between income levels and healthcare spending in different nations, with healthcare spending accounting for more than 10% of most industrialized countries' GDP.

Impact Analysis of COVID-19

Global COVID-19 cases have climbed above 516 million as of May 2022, and the death toll has exceeded 6.25 million. COVID-19 has disproportionately impacted specific racial and ethnic minority groups, as well as underserved and marginalized communities, highlighting the persistent challenges of health equity and health outcomes.

COVID-19 is causing a great deal of emotional, physical, and professional stress among health care personnel. The changing attitudes and behaviors of consumers, the integration of life sciences and health care, fast-growing digital health technology, new talent, and care delivery models, and clinical innovation advanced by COVID-19.

As sector players and the customers, they serve to adapt to a new world of remote working, virtual doctor visits, and a supply chain plagued by shortages of medical goods, employees, and services, the sector is reforming to become more customer-centric.

The Centers for Medicare and Medicaid Services data calculates that the U.S. national healthcare expenditure reached US$ 4.1 trillion in 2020 and is forecast to surpass US$ 6.2 trillion by 2028. According to the Commonwealth Fund, the U.S. spent nearly 17% of gross domestic product (GDP) on healthcare in 2018. Switzerland was the second-highest-ranking country, spending 12.2%. In addition, New Zealand and Australia dedicate only 9.3%.

Regional Analysis

By Component segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Hardware
Software
Services

Download Sample Report- https://www.astuteanalytica.com/industry-report/digital-therapeutics-market

By Application segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Preventive Applications
Prediabetes​
Obesity​
Nutrition​
Lifestyle Management​
Others​
Treatment/Care-related Applications​
Diabetes​
CNS Disorders​
Mental Health Disorder
Other CNS Disorders​
Chronic Respiratory Disorders​
Musculoskeletal Disorders​
Cardiovascular Diseases
Smoking Cessation​
Medication Adherence​
Gastrointestinal Disorders​
Substance Use & Addiction Management​
Rehabilitation & Patient Care​

By Sales Channel segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Business-to-business (B2B)
Employer
Healthcare Provider
Payers
Pharmaceutical Companies
Others
Business-to-consumer (B2C)
Patient
Caregiver

By Region segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Italy
Spain
Poland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Argentina
Brazil
Rest of South America

Key Players Insights

Livongo Health, Inc., Omada Health, Inc., Proteus Digital Health, Inc., Akili Interactive Labs, Inc., 2Morrow Inc., Click Therapeutics Inc., Happify Health, Kaia Health, Teladoc Health, Inc., Medtronic, Pear Therapeutics, Inc., ResMed and Voluntis among others are some key players in the global digital therapeutics market.

Request Full Report- https://www.astuteanalytica.com/request-sample/digital-therapeutics-market

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us:

Phone number: +18884296757

Email: sales@astuteanalytica.com

Visit our website: https://www.astuteanalytica.com/

This release was published on openPR.